ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HIMS vs LFST // FORWARD P/E MULTIPLE

Hims & Hers Health Inc. (NYSE) VS. LifeStance Health Group Inc. (NASDAQ) • 15-METRIC TALLY: HIMS 7 — LFST 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HIMS VS. LFST) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HIMS LFST SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 73.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 8.40% 1.20% +7.20 HIMS /roic <GO>
EV/EBITDA & P/E Valuation 37.7x 95.3x -57.60 HIMS /valuation <GO>
Free Cash Flow Yield 2.81% 2.11% +0.70 HIMS /fcf-yield <GO>
Operating Margin 4.50% 1.70% +2.80 HIMS /operating-margins <GO>
Net Profit Margin 5.50% 0.70% +4.80 HIMS /net-margins <GO>
Revenue Growth (YoY) 59.00% 13.90% +45.10 HIMS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.95 4.84 -0.89 LFST /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.1 64.8 -11.66 LFST /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.05 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 45.3x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $6.92B $5.21B $1.71B HIMS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HIMS REV LFST REV HIMS GROSS % LFST GROSS % HIMS FCF LFST FCF
FY 2025 $2.35B $1.42B 73.8% — $194.4M $110.0M
FY 2024 $1.48B $1.25B 79.5% — $184.6M $85.7M
FY 2023 $872.0M $1.06B — — $34.2M -$16.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HIMS // BETA 1.05
LFST // BETA —